India
After Bombay HC rap, FDA withdrawsorders against Cipla, MCA eateries
The Bombay High Court took a firm stance against the Maharashtra FDA, rebuking its treatment of Cipla and five eateries. The court underscored that the FDA's decisions compromised natural justice and displayed an inflexible approach. With the court's direction, the FDA rescinded
This story summarizes reporting from Times of India. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.
Read full story on Times of India →India — RK LAXMI
